Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experienceOpen heart, 2020-02, Vol.7 (1), p.e001144-e001144 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2020 Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2019-001144 ;PMID: 32180986Full text available |
|
2 |
Material Type: Article
|
Dietary sodium restriction prevents vascular endothelial growth factor inhibitor-induced hypertensionBritish journal of cancer, 2023-01, Vol.128 (2), p.354-362 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;The Author(s), under exclusive licence to Springer Nature Limited 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-022-02036-6 ;PMID: 36357702Full text available |
|
3 |
Material Type: Article
|
Continuous heart monitoring to evaluate treatment effects in pulmonary hypertensionOpen heart, 2024-05, Vol.11 (1), p.e002710 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2024-002710 ;PMID: 38719497Full text available |
|
4 |
Material Type: Article
|
Bevacizumab-induced hypertension and proteinuria: a genome-wide study of more than 1000 patientsBritish journal of cancer, 2022-02, Vol.126 (2), p.265-274 [Peer Reviewed Journal]2021. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2021. corrected publication 2021. ;The Author(s), under exclusive licence to Springer Nature Limited 2021, corrected publication 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01557-w ;PMID: 34616010Full text available |
|
5 |
Material Type: Article
|
Long-term use of antihypertensive medications, hypertension and colorectal cancer risk and mortality: a prospective cohort studyBritish journal of cancer, 2022-11, Vol.127 (11), p.1974-1982 [Peer Reviewed Journal]2022. The Author(s), under exclusive licence to Springer Nature Limited. ;The Author(s), under exclusive licence to Springer Nature Limited 2022. Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;The Author(s), under exclusive licence to Springer Nature Limited 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-022-01975-4 ;PMID: 36138074Full text available |
|
6 |
Material Type: Article
|
Hypertension in malignancy-an underappreciated problemOncotarget, 2018-04, Vol.9 (29), p.20855-20871Copyright: © 2018 Małyszko et al. 2018 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.25024 ;PMID: 29755695Full text available |
|
7 |
Material Type: Article
|
Hypertension and overall survival in metastatic colorectal cancer patients treated with bevacizumab-containing chemotherapyBritish journal of cancer, 2011-02, Vol.104 (4), p.599-604 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group Feb 15, 2011 ;Copyright © 2011 Cancer Research UK 2011 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2011.2 ;PMID: 21304526 ;CODEN: BJCAAIFull text available |
|
8 |
Material Type: Article
|
A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelinesOpen heart, 2021-10, Vol.8 (2), p.e001725 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001725 ;PMID: 34667092Full text available |
|
9 |
Material Type: Article
|
Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UKBritish journal of cancer, 2019-07, Vol.121 (2), p.109-116 [Peer Reviewed Journal]The Author(s) 2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2019 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-019-0481-y ;PMID: 31182765Full text available |
|
10 |
Material Type: Article
|
Association between serum resistin concentration and hypertension: A systematic review and meta-analysisOncotarget, 2017-06, Vol.8 (25), p.41529-41537Copyright: © 2017 Zhang et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.17561 ;PMID: 28525369Full text available |
|
11 |
Material Type: Article
|
Renin–angiotensin–aldosterone system inhibitors and the risk of mortality in patients with hypertension hospitalised for COVID-19: systematic review and meta-analysisOpen heart, 2020-11, Vol.7 (2), p.e001353 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2020 ;ISSN: 2053-3624 ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2020-001353 ;PMID: 33154144Full text available |
|
12 |
Material Type: Article
|
Characteristics and in-hospital outcomes of patients undergoing balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension: a time-trend analysis from the Japanese nationwide registryOpen heart, 2021-09, Vol.8 (2), p.e001721 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2021-001721 ;PMID: 34521747Full text available |
|
13 |
Material Type: Article
|
Quality of Life and the Cardiopulmonary Exercise Test in Pulmonary Arterial Hypertension PatientsArchivos de bronconeumología (English ed.), 2024-04, Vol.60 (4), p.253-255 [Peer Reviewed Journal]2024 SEPAR ;ISSN: 0300-2896 ;EISSN: 1579-2129 ;DOI: 10.1016/j.arbres.2024.01.016 ;PMID: 38402048Full text available |
|
14 |
Material Type: Article
|
Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100British journal of cancer, 2014-09, Vol.111 (6), p.1241-1248 [Peer Reviewed Journal]2015 INIST-CNRS ;Copyright Nature Publishing Group Sep 9, 2014 ;Copyright © 2014 Cancer Research UK 2014 Cancer Research UK ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/bjc.2014.430 ;PMID: 25117820 ;CODEN: BJCAAIFull text available |
|
15 |
Material Type: Article
|
Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertensionOncotarget, 2017-05, Vol.8 (18), p.29613-29624Copyright: © 2017 Amirjanians et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.16769 ;PMID: 28410199Full text available |
|
16 |
Material Type: Article
|
Effects of renal denervation on monocrotaline induced pulmonary remodelingOncotarget, 2017-07, Vol.8 (29), p.46846-46855Copyright: © 2017 Liu et al. 2017 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.15154 ;PMID: 28187460Full text available |
|
17 |
Material Type: Article
|
Lung tissue remodelling in MCT-induced pulmonary hypertension: a proposal for a novel scoring system and changes in extracellular matrix and fibrosis associated gene expressionOncotarget, 2016-12, Vol.7 (49), p.81241-81254Copyright: © 2016 Franz et al. 2016 ;ISSN: 1949-2553 ;EISSN: 1949-2553 ;DOI: 10.18632/oncotarget.13220 ;PMID: 27835899Full text available |
|
18 |
Material Type: Article
|
Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomesOpen heart, 2023-06, Vol.10 (1), p.e002268 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002268 ;PMID: 37280015Full text available |
|
19 |
Material Type: Article
|
Blood pressure status, trajectories and cardiovascular disease: the CoLaus|PsyCoLaus prospective studyOpen heart, 2024-02, Vol.11 (1), p.e002556 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2024 Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2023-002556 ;PMID: 38388190Full text available |
|
20 |
Material Type: Article
|
Prevalence and determinants of hypertension control among almost 100 000 treated adults in the UKOpen heart, 2021-02, Vol.8 (1), p.e001461 [Peer Reviewed Journal]Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. 2021 ;ISSN: 2053-3624 ;ISSN: 2398-595X ;EISSN: 2053-3624 ;DOI: 10.1136/openhrt-2020-001461 ;PMID: 33707223Full text available |